Literature DB >> 20413399

Relation of myocardial T2* to right ventricular function in thalassaemia major.

Francisco Alpendurada1, John-Paul Carpenter, Monica Deac, Paul Kirk, J Malcolm Walker, John B Porter, Winston Banya, Taigang He, Gill C Smith, Dudley J Pennell.   

Abstract

AIMS: Myocardial T2* cardiovascular magnetic resonance (CMR) provides a rapid and reproducible measure of cardiac iron loading and is being increasingly used worldwide for monitoring of transfusion-dependent thalassaemia patients. Although myocardial siderosis (T2* <20 ms) is associated with impaired left ventricular (LV) function, little is known of its relation with right ventricular (RV) function. The aim of this study was to investigate the relationship between cardiac T2* and RV function. METHODS AND
RESULTS: A retrospective analysis of 319 patients with beta-thalassaemia major presenting for their first CMR scan was performed (45.1% male, mean age 25.6 years). In patients with normal myocardial T2* (>20 ms), the RV ejection fraction (EF) was within the normal range in 98% of patients. When myocardial T2* was <20 ms, there was a progressive and significant decline in RV EF. There was a linear relationship between RV and LV EF.
CONCLUSION: Myocardial iron deposition is strongly associated with RV dysfunction, which mirrors the decrease in LV function seen with worsening cardiac iron loading. Right ventricular dysfunction may play a significant role in heart failure associated with myocardial siderosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413399     DOI: 10.1093/eurheartj/ehq106

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

1.  Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi-Kong Li; Vip Viprakasit; Mohsen S Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  On T2* magnetic resonance and cardiac iron.

Authors:  John-Paul Carpenter; Taigang He; Paul Kirk; Michael Roughton; Lisa J Anderson; Sofia V de Noronha; Mary N Sheppard; John B Porter; J Malcolm Walker; John C Wood; Renzo Galanello; Gianluca Forni; Gualtiero Catani; Gildo Matta; Suthat Fucharoen; Adam Fleming; Michael J House; Greg Black; David N Firmin; Timothy G St Pierre; Dudley J Pennell
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

Review 3.  Cardiac complications in beta-thalassemia: From mice to men.

Authors:  Sirinart Kumfu; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-09

4.  Early detection of right ventricular diastolic dysfunction by pulsed tissue Doppler echocardiography in iron loaded beta thalassemia patients.

Authors:  Hala Mounir Agha; Amal Beshlawy; Mona Hamdy; Alae Sobeih; Fatma El Zahrae; Inas Abd Abd El Satar; Antoine AbdelMassih; Fadwa Said; Ossama Abd El Aziz; Mona El Tagui; Dudley J Pennell
Journal:  Pediatr Cardiol       Date:  2014-10-08       Impact factor: 1.655

5.  Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.

Authors:  Gillian C Smith; Francisco Alpendurada; John Paul Carpenter; Mohammed H Alam; Vasili Berdoukas; Markissia Karagiorga; Vasili Ladis; Antonio Piga; Athanassios Aessopos; Efstathios D Gotsis; Mark A Tanner; Mark A Westwood; Renzo Galanello; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2011-07-06       Impact factor: 5.364

6.  Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major.

Authors:  Francisco Alpendurada; Gill C Smith; John-Paul Carpenter; Sunil V Nair; Mark A Tanner; Winston Banya; Carlo Dessi; Renzo Galanello; John Malcolm Walker; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-25       Impact factor: 5.364

7.  Right and left ventricular function and myocardial scarring in adult patients with sickle cell disease: a comprehensive magnetic resonance assessment of hepatic and myocardial iron overload.

Authors:  Flávia P Junqueira; Juliano L Fernandes; Guilherme M Cunha; Tadeu T A Kubo; Claudio M A O Lima; Daniel B P Lima; Marly Uellendhal; Sidney R Sales; Carolina A S Cunha; Viviani L R de Pessoa; Clarisse L C Lobo; Edson Marchiori
Journal:  J Cardiovasc Magn Reson       Date:  2013-09-19       Impact factor: 5.364

Review 8.  Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major.

Authors:  A John Baksi; Dudley J Pennell
Journal:  Front Pharmacol       Date:  2014-09-23       Impact factor: 5.810

Review 9.  Review of Journal of Cardiovascular Magnetic Resonance 2011.

Authors:  Dudley J Pennell; John Paul Carpenter; David N Firmin; Philip J Kilner; Raad H Mohiaddin; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-18       Impact factor: 5.364

10.  How early can myocardial iron overload occur in beta thalassemia major?

Authors:  Gaohui Yang; Rongrong Liu; Peng Peng; Liling Long; Xinhua Zhang; Weijia Yang; Shaohong Tan; Hongfei Pan; Xingjiang Long; Taigang He; Lisa Anderson; Yongrong Lai
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.